Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

5 results
Display

NSAID-induced Gastroenteropathy

Kim JW

  • KMID: 1767617
  • Korean J Gastroenterol.
  • 2008 Sep;52(3):134-141.
Non-steroidal anti-inflammatory drugs (NSAIDs) are used for the management of various conditions, such as pain, fever, inflammation, cancer, or cardiovascular diseases. These drugs may induce injury throughout the gastrointestinal tract....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antibiotics-associated Diarrhea and Other Gastrointestinal Abnormal Responses Regarding Helicobacter pylori Eradication

Kwon SB, Lee KL, Kim JS, Lee JK, Kim W, Jung YJ, Jeong JB, Kim JW, Kim BG

BACKGROUND/AIMS: Helicobacter pylori (H. pylori) is closely related with a wide range of gastrointestinal disease. One-week triple therapy is currently considered as the golden standard for the treatment of H....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gastroduodenal Injury in Patients with Low-Dose Enteric Coated Aspirin Treatment

Lee HL, Han DS, Kim JB, Park JY, Sohn JH, Hahm JS, Ahn YH

  • KMID: 881582
  • Korean J Gastroenterol.
  • 2003 Sep;42(3):190-194.
BACKGROUND/AIMS: Low-dose aspirin therapy is widely used to prevent cardiovascular thrombotic events. However, the safety of low-dose aspirin therapy in the gastrointestinal tract is uncertain. Our aim was to evaluate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gastrointestinal Side Effect Profile Due to the Use of Alendronate in the Treatment of Osteoporosis

Aki S, Eskiyurt N, Akarirmak , Tuzun F, Eryavuz M, Alper S, Arpacioglu O, Atalay F, Kavuncu V, Kokino S, Kuru O, Nas K, Ozerbil O, Savas G, Sendur OF, Soy D, Akyuz G

The aim of our study was to evaluate the upper gastrointestinal (GI) tract side effect profile in 759 female patients that had taken alendronate (10 mg/day), for at least 6...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Improved Gastrointestinal Symptoms and Quality of Life after Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Receiving Tacrolimus

Hwang HS, Hyoung BJ, Kim S, Oh HY, Kim YS, Kim JK, Kim YH, Kim YL, Kim CD, Shin GT, Yang CW

It is reported that a conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) relieves gastrointestinal (GI) symptom burden and improves health-related quality of life (HRQoL). However, it is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr